U. S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                  FORM 10-QSB
(Mark One)
[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF 1934

     For  the  quarter  ended  July  31,  2002
                               ---------------

[ ]  TRANSITION  REPORT  UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT  OF  1934

For  the  transition  period  from  __________________  to  ___________________

                          Commission File No. 000-32089
                                              ---------

                                 FAR GROUP INC.
                                 --------------
                 (Name of Small Business Issuer in its Charter)

Washington                                                           91-2023071
----------                                                           ----------
(State or Other Jurisdiction of                                (I.R.S. Employer
incorporation or organization)                                Identification No)

                          1286 Homer Street, 4th Floor
                   Vancouver, British Columbia, Canada V6B 2Y5
                   -------------------------------------------
                    (Address of Principal Executive Offices)

                                 (604) 689-5255
                                 --------------
                            Issuer's Telephone Number

                              210-580 Hornby Street
                   Vancouver, British Columbia,Canada V6C 3B6
          -------------------------------------------------------------
          (Former Name or Former Address, if changed since last Report)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that  the  Company  was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.

      (1)     Yes   X      No             (2)     Yes    X       No
                   ---         ---                      ---           ---

     (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

                                 Not applicable

                     (APPLICABLE ONLY TO CORPORATE ISSUERS)

State the number of shares outstanding of each of the Issuer's classes of common
equity,  as  of  the  latest  practicable  date:

                                 August 15, 2002

                        Common - 15,850,000 common shares

                       DOCUMENTS INCORPORATED BY REFERENCE

A  description of any "Documents Incorporated by Reference" is contained in Item
6  of  this  Report.

    Transitional Small Business Issuer Format     Yes  X        No
                                                      ---          ---


<PAGE>
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.

The  Financial  Statements  of the Company required to be filed with this 10-QSB
Quarterly Report were prepared by management and commence on the following page,
together  with  related  notes.  In  the  opinion  of  management, the Financial
Statements  fairly  present  the  financial  condition  of  the  Company.

<TABLE>
<CAPTION>
FAR  Group,  Inc.
(A  Development  Stage  Company)
Interim  Balance  Sheet


                                                                               July 31,     April 30,
                                                                                 2002         2002
                                                                                  $             $
                                                                             (unaudited)    (audited)
<S>                                                                          <C>           <C>
ASSETS

Current Assets

Cash                                                                             238,652        4,645
------------------------------------------------------------------------------------------------------
Total Assets                                                                     238,652        4,645
======================================================================================================

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

Accounts payable                                                                  36,476       33,750
Accrued liabilities                                                                  600          550
Note payable (Note 4)                                                                  -       35,000
------------------------------------------------------------------------------------------------------
Total Liabilities                                                                 37,076       69,300
------------------------------------------------------------------------------------------------------
Contingency (Note 1)
Commitment (Note 5)

Stockholders' Equity

Common Stock: $0.0001 par value; authorized 100,000,000 common shares;
15,850,000 and 15,600,000 shares issued and outstanding respectively               1,585        1,560

Additional Paid-in Capital                                                       309,415       24,440
------------------------------------------------------------------------------------------------------
                                                                                 311,000       26,000
------------------------------------------------------------------------------------------------------
Preferred Stock: $.0001 par value; authorized 20,000,000 preferred shares;
none issued
------------------------------------------------------------------------------------------------------
Deficit Accumulated During the Development Stage                                (109,424)     (90,655)
------------------------------------------------------------------------------------------------------
Total Stockholders' Equity                                                       201,576      (64,655)
------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity                                       238,652        4,645
======================================================================================================
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


<PAGE>
<TABLE>
<CAPTION>
FAR Group, Inc.
(A Development Stage Company)
Interim Statements of Operations


                                                   Accumulated
                                                       From
                                                  March 24, 2000       Three months ended
                                                     (Date of
                                                    Inception)        July 31,      July 31,
                                                 to July 31, 2002       2002          2001
                                                        $                $             $
                                                   (unaudited)      (unaudited)   (unaudited)
<S>                                             <C>                 <C>           <C>
Revenue                                                         -
----------------------------------------------------------------------------------------------
Expenses

Accounting and legal                                       47,173        12,589         3,255
Business development                                        5,000         5,000             -
Consulting fees                                            15,000             -             -
License written-off                                        35,000             -             -
Office                                                      1,915           398           448
Transfer agent and filing fees                              5,336           782           858
----------------------------------------------------------------------------------------------
Net loss                                                 (109,424)      (18,769)       (4,561)
==============================================================================================
Net Loss Per Share                                                            -             -
==============================================================================================
Weighted Average Number of Shares Outstanding
(stock split applied retroactively)                                  15,624,000    15,600,000
==============================================================================================
</TABLE>

(Diluted  loss  per share has not been presented as the result is anti-dilutive)


(See  Accompanying  Notes  to  the  Interim  Financial  Statements)


<PAGE>
<TABLE>
<CAPTION>
FAR Group, Inc.
(A Development Stage Company)
Interim Statements of Cash Flows


                                                                    Three months ended
                                                                   July 31,      July 31,
                                                                     2002          2001
                                                                      $             $
                                                                 (unaudited)   (unaudited)
<S>                                                              <C>           <C>
Cash Flows From Operating Activities

Net loss                                                             (18,769)       (4,561)

Changes in operating assets and liabilities:

Accounts payable and accrued liabilities                               2,776         2,407
-------------------------------------------------------------------------------------------
Net Cash Used by Operating Activities                                (15,993)       (2,154)
-------------------------------------------------------------------------------------------
Cash Flows From Financing Activities

Common shares issued                                                 250,000             -
-------------------------------------------------------------------------------------------
Increase (Decrease) In Cash                                          234,007        (2,154)

Cash - Beginning of Period                                             4,645         2,361
-------------------------------------------------------------------------------------------
Cash - End of Period                                                 238,652           207
===========================================================================================

Non-Cash Financing Activities

A $35,000 note payable was assumed by the Company for the
acquisition of a License from a director which was forgiven on
July 12, 2002 (Notes 3 and 4)                                              -             -
===========================================================================================

Supplemental Disclosures

Interest paid                                                              -             -
Income tax paid                                                            -             -
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


<PAGE>
FAR Group, Inc.
A Development Stage Company)
Notes to the Interim Financial Statements
July 31, 2002
(unaudited)


1.   Development  Stage  Company

     FAR  Group,  Inc.  herein  (the "Company") was incorporated in the State of
     Washington,  U.S.A.  on  March  24, 2000. The Company acquired a license to
     market  and  distribute  vitamins,  minerals,  nutritional supplements, and
     other  health  and  fitness  products  in  which the grantor of the license
     offers  these  products  for sale from various suppliers on their Web Site.
     The  Company is currently developing a marketing strategy to offer personal
     care  products  through a kiosk-based ordering system. Once the kiosk-based
     marketing  strategy  is  developed,  it  will serve as another distribution
     network  for  both  of  its  product  lines.

     The  Company  is  in the development stage. In a development stage company,
     management  devotes  most  of its activities in developing a market for its
     products.  Planned  principal activities have not yet begun. The ability of
     the  Company  to  emerge  from  the  development  stage with respect to any
     planned  principal  business  activity  is  dependent  upon  its successful
     efforts  to  raise  additional  equity  financing  and/or attain profitable
     operations.  There  is  no guarantee that the Company will be able to raise
     any  equity  financing  or  sell  any of its products at a profit. There is
     substantial  doubt  regarding  the Company's ability to continue as a going
     concern.

     The  Company  filed an SB-2 Registration Statement with the U.S. Securities
     Exchange  Commission  which  was declared effective in January 2001. During
     fiscal  2001,  the Company sold and issued 1,000,000 common shares at $0.01
     per  share  for  cash  proceeds  of $10,000. During the period, the Company
     pursuant  to  a private placement issued 250,000 common shares at $1.00 per
     share for cash proceeds of $250,000. The Company trades on the OTC Bulletin
     Board  under  the  symbol  FGRI.


2.   Summary  of  Significant  Accounting  Policies

     (a)  Year  end

     The Company's fiscal year end is April 30.

     (b)  License

          The  cost  to  acquire  the  License  was  initially  capitalized. The
          carrying value of the License is evaluated in each reporting period to
          determine if there were events or circumstances which would indicate a
          possible  inability to recover the carrying amount. Such evaluation is
          based on various analyses including assessing the Company's ability to
          bring  the  commercial  applications  to market, related profitability
          projections  and  undiscounted cash flows relating to each application
          which  necessarily  involves significant management judgment. Where an
          impairment  loss  has  been  determined  the  carrying  amount  is
          written-down  to fair market value. Fair market value is determined as
          the amount at which the license could be sold in a current transaction
          between  willing  parties.  The  License  has  been  written-off  to
          operations  due to the lack of historical cash flow of the license and
          lack  of  a  market  to  resell  the  license.

     (c)  Cash  and  Cash  Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or less at the time of issuance to be cash equivalents.

     (d)  Revenue  Recognition

          The  Company will receive from the Grantor of the license, commissions
          of  one-half of all the profit on all sales made through the Grantor's
          Web  Site. The commission revenue will be recognized in the period the
          sales have occurred. The Company will report the commission revenue on
          a  net  basis as the Company is acting as an Agent for the Grantor and
          does not assume any risks or rewards of the ownership of the products.
          This  policy  is  prospective  in  nature  as  the Company has not yet
          generated  any  revenue.


<PAGE>
2.   Summary  of  Significant  Accounting  Policies

     (e)  Use  of  Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.

     (f)  Interim  Financial  Statements

          These interim unaudited financial statements have been prepared on the
          same  basis  as  the annual financial statements and in the opinion of
          management,  reflect  all  adjustments,  which  include  only  normal
          recurring  adjustments,  necessary  to  present  fairly  the Company's
          financial  position,  results  of  operations  and  cash flows for the
          periods  shown.  The  results  of  operations for such periods are not
          necessarily  indicative of the results expected for a full year or for
          any  future  period.


3.   License

     The  Company's asset is a license to market vitamins, minerals, nutritional
     supplements and other health and fitness products through the Grantor's Web
     Site.  The  Company  desires  to  market  these  products  to  medical
     practitioners,  alternative  health professionals, martial arts studios and
     instructors,  sports  and  fitness  trainers,  other  health  and  fitness
     practitioners,  school  and  other  fund raising programs and other similar
     types of customers in Minnesota. The license was acquired on April 13, 2000
     for  a  term of three years. The Company must pay an annual fee of $500 for
     maintenance  of  the Grantor's Web Site commencing on the anniversary date.
     The Grantor waived the annual fee due on April 13, 2001. The Grantor of the
     license  retains  50%  of  the  profits.

     The Company paid total consideration of $35,000 for the license with a note
     payable  of  $35,000.  See  Note  4.

     The  License  was  written-off  to operations due to the lack of historical
     cash  flow  and  lack of a market to resell the license. However, it is the
     Company's intention to conduct a survey to determine its core target market
     from  amongst  the potential clients under its Vitamineralherb.com license,
     hire  commissioned  sales  staff, establish an office, advertise, and begin
     making  sales.


4.   Related  Party  Transaction

     The License referred to in Note 3 was assigned to the Company by the former
     sole  director and former President of the Company for consideration of the
     assumption of a note payable of $35,000 to Vitamineralherb.com. On December
     12,  2000,  on  behalf  of the Company, the former President of the Company
     repaid the note payable to Vitamineralherb.com for which the Company issued
     a  note  payable  of  $35,000  to  the former President of the Company. The
     $35,000  note payable to the former President of the Company was unsecured,
     non-interest  bearing  and  was repayable by December 31, 2010. On July 12,
     2002,  the  former  President  of  the Company forgave the note payable and
     released  the Company from all obligations. The License was recorded at the
     transferor's cost of $35,000, which was also fair market value at the time.
     The  Grantor  of  the  License  is  not  related  to  the  Company.


5.   Commitment

     The  Company  entered into a Business Agreement with Magnum Financial Corp.
     ("Magnum")  whereby  Magnum  will  assist  the Company with the approval of
     trading  on the OTC Bulletin Board. The Company paid $5,000 upon acceptance
     of this agreement and was to pay $5,000 upon listing for trading on the OTC
     BB  and  a  further $5,000 three weeks after listing for trading on the OTC
     BB.  This  agreement  was  cancelled  and  the  amount  owing  was  waived.


<PAGE>
6.   Common  Stock

     (a)  The  Company's Board of Directors approved a six for one forward split
          with  a  record  date  of  August  31,  2001.

     (b)  During  the  period  ended  July  31,  2002,  pursuant  to  a  private
          placement, the Company issued 250,000 common shares at $1.00 per share
          for  total  cash  consideration  of  $250,000.


Item 2.   Management's  Discussion  and  Analysis  or  Plan  of  Operation
---------------------------------------------------------------------------

The  following  discussion  and  analysis of FAR Group's financial condition and
results  of  operations  should  be  read  in  conjunction  with  the  Financial
Statements  and accompanying notes and the other financial information appearing
elsewhere  in  this  report.

PLAN  OF  OPERATION
-------------------
During  the  period  from  March  24  2000  through July 31, 2002, FAR Group has
engaged  in  no  significant  operations  other  than organizational activities,
acquisition  of  the  rights  to  market  Vitamineralherb,  preparation  for
registration  of  its  securities  under the Securities Act of 1933, as amended,
preparation  of a supplementary business plan and completing a private placement
to  fund  this secondary division. No revenues were received by FAR Group during
this  period.

The  original  shareholder  paid  legal expenses upon inception in the amount of
$16,000  for  which he received 1,600,000 shares of common stock of the Company.

The  Company  filed  an  SB-2  Registration  Statement  with the U.S. Securities
Exchange  Commission  which  was declared effective in January 2001. The Company
sold  and issued 1,000,000 common shares at $0.01 per share for cash proceeds of
$10,000.  The  Company  trades  on the OTC Bulletin Board under the symbol FGRI.

The Company is presently in negotiations to extend its license for an additional
three  years  to  market  vitamins,  minerals, nutritional supplements and other
health  and  fitness  products  in Minnesota through the Vitamineralherb.com web
site.  The  current  license  expires  in April 2003.  There can be no assurance
that  the  Company will be successful in extending its license to market through
Vitamineralherb.com  although the Company has been assured that the extension is
forthcoming.

FAR  Group's  business  plan  in  connection  with  the license to sell products
through  the  Vitamineralherb.com  web  site  is to determine the feasibility of
selling products to targeted markets.   In order to determine the feasibility of
its  business plan, FAR Group plans for the next six months, provided it is able
to  extend  its  license  to  sell  through the Vitamineralherb.com web site, to
conduct  research  into these various potential target markets. Should FAR Group
determine  that  the  exploitation  of  the  license is feasible, it will engage
salespeople  to  market  the  products.  Based primarily on discussions with the
licensor,  FAR Group believes that during its first operational quarter, it will
need  a capital infusion of approximately $85,000 to achieve a sustainable sales
level  where  ongoing  operations  can  be  funded out of revenues. This capital
infusion  is  intended  to  cover  costs  of  advertising, hiring and paying two
salespeople,  and  administrative  expenses.  In  addition,  FAR Group will need
approximately  $260,000  in the event it determines that its market will not pay
in  advance  and  it  will  have to extend credit. FAR Group will have to obtain
additional  financing  through  an  offering or capital contributions by current
shareholders.

In  addition  to  its  Vitamineralherb  business development, during the quarter
ended July 31, 2002, FAR Group initiated the development of a marketing strategy
to  offer  consumers  high  quality,  competitive  priced personal care products
through a kiosk-based ordering system with additional website, mail-in and phone
orders.  Once  developed,  the  Company intends to use the kiosk-based marketing
strategy  as  another  distribution network for both its Vitamineraherb products
and  the  products  of Health Anti-Aging Lifestyle Options, Inc. ("HALO").  Upon
completion  of  the development of its kiosk based marketing system, the Company
intends  to  enter  into a marketing partnership with HALO to sell HALO's health
and  wellness  products.  There  can  be  no assurances that the Company will be
successful  in  developing  its  kiosk based marketing system or that it will be
able  to  secure  products  for  distribution  through  this  system.

For  the current quarter ending July 31, 2002, FAR Group anticipates incurring a
loss  as  a result of expenses associated with setting up a company structure to
begin  implementing  its  business plans. FAR Group anticipates that until these
procedures  are  completed,  it  will not generate revenues, and may continue to
operate  at  a  loss thereafter, depending upon the performance of the business.


<PAGE>
FAR Group remains in the development stage. FAR Group's balance sheet as of July
31,  2002, reflects total assets of $238,652 comprising of all cash. The Company
had  total  liabilities  of $37,076 of which $22,000 represented advances from a
shareholder  to cover the Company's operating expenses in the past.  The Company
has incurred a loss of $109,424 to date. During the quarter ended July 31, 2002,
the Company issued 250,000 shares of common stock to HALO on a private placement
basis  for  proceeds  of $250,000.  The proceeds from this private placement are
intended  for  general working capital in connection with the development of its
kiosk  based  marketing  system and none of the proceeds are intended to be used
towards  the  Vitamineralherb  segment  of  the  Company's  business.

Liquidity
---------

The  Company  had cash on hand of $238,652 as at July 31, 2002.  During the most
recent  quarter,  the Company's former sole director and officer, forgave a note
payable and released the Company in connection with a $35,000 obligation for the
initial  acquisition  of  the  Vitamineralherb  license.

The  Company  has allocated a significant portion of the cash on hand to working
capital  for  the  development  of  the  kiosk  marketing  system  and  related
administrative  costs.  FAR  Group will need additional capital to carry out its
business  plan or to engage in a business combination. No commitments to provide
additional  funds  have  been  made  by  management  or  other  shareholders.
Accordingly,  there  can  be  no  assurance  that  any  additional funds will be
available  on  terms  acceptable  to  FAR  Group  or  at  all.  FAR Group has no
commitments  for  capital  expenditures.

In  addition,  FAR  Group may engage in a combination with another business. FAR
Group has engaged in discussions concerning potential business combinations, but
has  not  entered  into  any  agreement  for  such  a  combination.

FAR  Group's  failure  to  generate  revenues  and  conduct operations since its
inception  raise  substantial  doubt  about FAR Group's ability to continue as a
going concern. FAR Group will require substantial working capital, and currently
has  inadequate  capital  to fund its business. FAR Group may be unable to raise
the  funds  necessary  for  implementing its business plan, which could severely
limit  its  operations  and  cause  its  stock  to  be  worthless.


PART II - OTHER INFORMATION

Item 1.   Legal  Proceedings.

          None; not applicable.

Item 2.   Changes  in  Securities.

          During  the  quarter  ended  July 31, 2002, the Company issued 250,000
"unregistered"  and "restricted" shares of its common stock to Health Anti-Aging
Lifestyle  Options,  Inc.  ("HALO") pursuant to a private placement financing of
$250,000  to  be used in developing a kiosk style marketing system.  The Company
intends  to enter into a marketing partnership with HALO to sell HALO's products
once the kiosk marketing system is in place.  The Company believe that the offer
and  sale  of  these securities was exempt from the registration requirements of
the  Securities Act of 1933, as amended, pursuant to Rule 506 of Regulation D of
the  Securities  and  Exchange  Commission  and  from  various  similar  state
exemptions.

Item 3.   Defaults  Upon  Senior  Securities.

          None; not applicable.

Item 4.   Submission  of  Matters  to  a  Vote  of  Security  Holders.

     On  July  19,  2002,  the  Company  held  an  annual general meeting of its
stockholders  in  Vancouver,  British  Columbia.  At  the  meeting the following
persons  were elected to serve as directors of the Company until the next annual
meeting  of  the  Company's stockholders or until the election or appointment of
their  successors:

     -    Jim  Glavas
     -    Aaron  Kirsten
     -    Larry  Bishop


<PAGE>
          At  the  meeting,  the  stockholders  also  ratified and confirmed the
appointment  of  Manning  Elliott,  Chartered  Accountants  as  the  Company's
independent  auditors  for  the  fiscal  year  ended  April  30,  2003.

Item 5.   Other  Information.

          The  Company's  Board  of  Directors  held a meeting on July 19, 2002,
immediately  after  the  completion  of the meeting of the stockholders.  At the
Board  meeting  the  following  persons  were elected to serve in the capacities
indicated  for  the  ensuing  year  or  until  they  are  replaced by the Board:

     -    Jim  Glavas  -  President,  CEO  and  CFO

     -    Coreena  Hansen  -  Secretary

Item 6.   Exhibits  and  Reports  on  Form  8-K.

          (a)  Exhibits.

               Description  of  Exhibit                         Exhibit  No.
               ------------------------                         ------------

               Subscription Agreement with Health Anti-Aging
               Lifestyle Options, Inc.                             99.1

          (b)  Reports  on  Form  8K

               -    Form  8K  filed  on  July  23,2002

          DOCUMENTS INCORPORATED BY REFERENCE

          None.


                                   SIGNATURES


Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
Registrant  has  duly  caused  this  Report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.


                                        FAR  GROUP  INC.



Date:  August 30, 2002                  By:   /s/  Jim Glavas
       --------------------                  -----------------------------------
                                              Jim Glavas
                                              President, CEO, CFO and Director



Date:  August 30, 2002                  By:   /s/  Aaron Kirsten
       --------------------                  -----------------------------------
                                              Aaron Kirsten
                                              Director



Date:  August 30, 2002                  By:   /s/  Larry Bishop
       --------------------                  -----------------------------------
                                              Larry Bishop
                                              Director


<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
this  Report  has  been  signed  below by the following persons on behalf of the
Company  and  in  the  capacities  and  on  the  dates  indicated:



Date:  August 30, 2002                  By:   /s/  Jim Glavas
       --------------------                  -----------------------------------
                                              Jim Glavas
                                              President, CEO, CFO and Director



Date:  August 30, 2002                  By:   /s/  Aaron Kirsten
       --------------------                  -----------------------------------
                                              Aaron Kirsten
                                              Director



Date:  August 30, 2002                  By:   /s/  Larry Bishop
       --------------------                  -----------------------------------
                                              Larry Bishop
                                              Director



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with  the  Quarterly Report of FAR Group Inc. (the "Company") on
Form  10-QSB for the period ended July 31, 2002 as filed with the Securities and
Exchange  Commission on the date here of (the "Report"), I, Jim Glavas, CEO, CFO
and  President  of  the Company, certify, pursuant to 18 U.S.C. Section 1350, as
adopted  pursuant  to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best  of  our  belief  and  knowledge:

          (1)  The  Report  fully  complies  with  the  requirements  of Section
     13(a)  or  15(d)  of  the  Securities  Exchange  Act  of  1934;  and

          (2)  The  information contained in this Report fairly presents, in all
     material respects, the financial condition and results of operations of the
     Company.



Dated:  August 30, 2002                      /s/  Jim Glavas
                                             -----------------------------
                                             Jim Glavas
                                             CEO, CFO and President


<PAGE>